ST Sensata narrowly misses Q4 2025 EPS estimates shares dip 041 in todays trading CAC Camden Natl posts nearexpected Q4 2025 EPS shares slip 04 on mild investor caution CVSA Covista delivers 89 percent first quarter 2026 EPS beat shares rise modestly on upbeat investor reaction AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks Is BRC BRCC stock in a strong position Q4 2025 EPS Misses Estimates VHI Valhi posts steep Q4 2025 EPS miss shares fall 201 on weak quarterly results